Updated opioid prescribing guidelines: Implications for nurse practitioners

Area of Science:

• Public Health
• Clinical Practice Guidelines
• Pharmacology

Background:

• The opioid epidemic is a major US public health issue.
• Nurse practitioners (NPs) are vital in managing this crisis.
• The CDC released updated opioid prescribing guidelines in 2022.

Purpose of the Study:

• To outline the implications of the 2022 CDC guideline for NPs.
• To focus on key areas of opioid prescribing: initiation, dosage, duration, and risk mitigation.
• To support NPs in optimizing patient-centered care for the opioid crisis.

Main Methods:

• Review of the Centers for Disease Control and Prevention (CDC) 2022 clinical practice guideline.
• Analysis of guideline implications for nurse practitioners (NPs).
• Focus on four critical prescribing areas: initiation, dosage, duration, and risk management.

Main Results:

• The guideline provides a framework for NPs on opioid initiation decisions.
• It details appropriate opioid selection, dosage, and duration.
• It emphasizes risk assessment and mitigation strategies for safer prescribing.

Conclusions:

• Adherence to the CDC guideline helps NPs optimize opioid prescribing.
• Implementing the guideline supports patient-centered care aligned with public health goals.
• NPs are essential in combating the ongoing opioid crisis through informed prescribing.